These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2273625)

  • 1. Effect of cyclophosphamide pulse therapy in a patient with intractable lupus nephritis.
    Shibasaki T; Matsumoto H; Ohno I; Matsuda H; Kanai T; Ishimoto F; Sakai O
    Jpn J Med; 1990; 29(4):414-6. PubMed ID: 2273625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T; Igarashi T; Shimizu A; Itoh Y
    J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
    Williams W; Bhagwandass A; Sargeant LA; Shah D
    Lupus; 2003; 12(8):640-5. PubMed ID: 12945726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy].
    Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Kurata T; Arimori S
    Ryumachi; 1989 Aug; 29(4):291-6. PubMed ID: 2617371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
    Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic value of serial renal biopsies in lupus nephritis.
    Moroni G; Pasquali S; Quaglini S; Banfi G; Casanova S; Maccario M; Zucchelli P; Ponticelli C
    Am J Kidney Dis; 1999 Sep; 34(3):530-9. PubMed ID: 10469865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
    Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S; Gupta D; Ali S; Gupta P
    Saudi J Kidney Dis Transpl; 2017; 28(5):1069-1077. PubMed ID: 28937065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
    BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe nephrotic syndrome with reversible acute kidney failure in lupus-associated membranous nephropathy].
    Pauli-Magnus C; Mettang T; Kuhlmann U
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):788-92. PubMed ID: 10414228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphologic transformation of renal lesions by steroid treatment and its therapeutic implication in a patient with lupus nephritis].
    Saito M; Nakabayashi K; Maemura C; Kitamoto K; Nagasawa T
    Ryumachi; 1990 Jun; 30(3):190-5; discussion 195-7. PubMed ID: 2244253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of lupus vasculopathy associated with lupus nephritis class IV-G (A)].
    Eguchi E; Shimazu K; Takaori K; Nishiguchi K; Mori K; Yorifuji S; Murakami T; Koshikawa M; Tanaka A; Kuwahara T
    Nihon Jinzo Gakkai Shi; 2010; 52(2):147-53. PubMed ID: 20415236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.